Nasopharyngeal Carcinoma Clinical Trials in Chengdu, Sichuan
6 recruitingChengdu, Sichuan, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Nasopharyngeal Carcinoma
Sun Yat-sen University593 enrolled26 locationsNCT06239727
Recruiting
Phase 3
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Ming-Yuan Chen346 enrolled15 locationsNCT07328854
Recruiting
Phase 1Phase 2
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
Recurrent or Metastatic Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979
Recruiting
Phase 2
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech70 enrolled15 locationsNCT06839066
Recruiting
Phase 2
Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute170 enrolled1 locationNCT05508347
Recruiting
Phase 2
Adebrelimab and Chemoradiotherapy in High-risk LANPC
Nasopharyngeal CancerNasopharyngeal Carcinoma
Sun Yat-sen University50 enrolled4 locationsNCT06349889